Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease
Completed · Phase 2 · Has a placebo group
Conditions studied: Chronic Kidney Disease
In brief
The purpose of the study is to evaluate the efficacy, safety and tolerability of balcinrenone/dapagliflozin compared with dapagliflozin alone on patients with chronic kidney disease (CKD) and albuminuria. This study will evaluate the effect of the balcinrenone/dapagliflozin on urinary albumin-to-creatinine ratio (UACR), compared with dapagliflozin in patients with CKD. This is a dose-finding study aiming to identify an optimal dose of balcinrenone/dapagliflozin for a future Phase III study in patients with CKD.
Key facts
- Study ID
- NCT06350123
- Run by
- AstraZeneca
- People needed
- 324
- Starts
- 2024-05-01
- Expected to finish
- 2025-05-09
- Last updated by the study team
- 2026-06-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Glendale, California, United States
- Research Site — Waterbury, Connecticut, United States
- Research Site — Hialeah, Florida, United States
- Research Site — Miami Lakes, Florida, United States
- Research Site — Annapolis, Maryland, United States
- Research Site — New Bern, North Carolina, United States
- Research Site — El Paso, Texas, United States
- Research Site — Houston, Texas, United States
- Research Site — Houston, Texas, United States
- Research Site — San Antonio, Texas, United States
- Research Site — Ogden, Utah, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Norfolk, Virginia, United States
- Research Site — Linz, Austria
- Research Site — Sankt Pölten, Austria
- Research Site — Vienna, Austria
- Research Site — Vienna, Austria
- Research Site — Vienna, Austria
- Research Site — Vienna, Austria
- Research Site — Wels, Austria
- Research Site — Porto Alegre, Brazil
- Research Site — São Paulo, Brazil
- Research Site — São Paulo, Brazil
- Research Site — Sheffield, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.